Tejara Capital LTD Sutro Biopharma, Inc. Transaction History

Tejara Capital LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.92 - $5.33 $25,482 - $46,514	8,727 Added 4.49%	203,145 $595 Million
Q1 2024 May 14, 2024	SELL	$3.27 - $5.65 $106,389 - $183,822	-32,535 Reduced 14.34%	194,418 $1.1 Billion
Q4 2023 Feb 12, 2024	BUY	$2.07 - $4.54 $286,220 - $627,750	138,271 Added 155.92%	226,953 $974 Million
Q2 2023 Aug 11, 2023	BUY	$4.25 - $5.88 $187,845 - $259,890	44,199 Added 99.36%	88,682 $412 Million
Q1 2023 May 12, 2023	BUY	$4.48 - $8.45 $199,283 - $375,881	44,483 New	44,483 $206 Million

137

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $140M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Tejara Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Tejara Capital LTD with notifications on news.